Targeting immune cell glutamyl-prolyl-transfer RNA synthetase 1 (EPRS1) to prevent fibrosis after tubulointerstitial nephritis.


Journal

Kidney international
ISSN: 1523-1755
Titre abrégé: Kidney Int
Pays: United States
ID NLM: 0323470

Informations de publication

Date de publication:
May 2024
Historique:
received: 01 02 2024
accepted: 12 02 2024
medline: 21 4 2024
pubmed: 21 4 2024
entrez: 20 4 2024
Statut: ppublish

Résumé

Glutamyl-prolyl-transfer RNA synthetase 1 is an enzyme that connects glutamic acid and proline to transfer RNA during protein synthesis. In this issue, a study by Kang et al. examined the role of the immune cell glutamyl-prolyl-transfer RNA synthetase 1 in toxin-induced tubulointerstitial nephritis mice. The study demonstrated that blocking glutamyl-prolyl-transfer RNA synthetase 1 may be a therapeutic target to attenuate fibrosis after toxin-induced tubulointerstitial nephritis.

Identifiants

pubmed: 38642990
pii: S0085-2538(24)00157-1
doi: 10.1016/j.kint.2024.02.007
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

924-926

Informations de copyright

Copyright © 2024 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Auteurs

Shishir Kumar Patel (SK)

Division of Nephrology, Johns Hopkins University, Baltimore, Maryland, USA.

Hamid Rabb (H)

Division of Nephrology, Johns Hopkins University, Baltimore, Maryland, USA. Electronic address: hrabb1@jhmi.edu.

Classifications MeSH